Earlier Sustained Virologic Response End Points for Regulatory Approval and Dose Selection of Hepatitis C Therapies
Authors:
- Jeffry FlorianJFJeffry Florian
- Wendy CarterWCWendy Carter
- Russell D. FleischerRFRussell D. Fleischer
- Thomas S. HammerstromTHThomas S. Hammerstrom
- Pravin R. JadhavPJPravin R. Jadhav
- Wen ZengWZWen Zeng
- Jeffrey MurrayJMJeffrey Murray
- Debra BirnkrantDBDebra Birnkrant
- 1 June 2013
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 144 (7) , 1450-1455.e2
Abstract
No abstract availableKeywords
Funding Information
- Oak Ridge Institute for Science and Education
This publication has 17 references indexed in Scilit:
- Therapeutics: New drugs hit the targetNature, 2011
- Boceprevir for Previously Treated Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2011
- Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much MoreClinical Infectious Diseases, 2011
- A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and RibavirinGastroenterology, 2010
- Twelve weeks posttreatment follow‐up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin†Hepatology, 2010
- Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin in HIV‐Infected and HIV‐Uninfected PatientsClinical Infectious Diseases, 2009
- Diagnosis, management, and treatment of hepatitis C: An update # † ‡Hepatology, 2009
- Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibodyLiver International, 2009
- Long‐term clinical and virological outcomes of chronic hepatitis C after successful interferon therapyJournal of Medical Virology, 2004
- Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon α for chronic hepatitis CJournal of Hepatology, 2003